Soleno Therapeutics (SLNO) Acquisitions (2017)
Soleno Therapeutics' (SLNO) quarterly Acquisitions came in at -$408.0 in Q4 2017, down 100.12% on a QoQ basis from $350000.0 in Q3 2017.
Soleno Therapeutics (SLNO) Acquisitions (2017) Analysis & Trends
Soleno Therapeutics (SLNO) has 1 years of Acquisitions data on file, last reported at -$408.0 in Q4 2017.
- On a quarterly basis, Acquisitions changed N/A year-over-year to -$408.0 in Q4 2017; TTM through Dec 2017 was $349592.0, a N/A change from a year earlier, with the FY2017 full-year figure at $572592.0, changed N/A from the prior year.
- Acquisitions for Q4 2017 stood at -$408.0, down from $350000.0 in the prior quarter.
- Over the last five years, Acquisitions for SLNO reached as high as $350000.0 in Q3 2017 and fell as low as -$408.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -408.00 |
| Sep 30, 2017 | 350,000.00 |